Newsroom
Sorted by: Latest
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
CrowdStrike Named the Only Customers’ Choice in the 2026 Gartner® Peer Insights™ ‘Voice of the Customer’ for Identity Threat Detection and Response (ITDR)
AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced it has been named the only Customers’ Choice in the 2026 Gartner Peer Insights™ ‘Voice of the Customer’ for Identity Threat Detection and Response (ITDR) report.1 CrowdStrike received the most 5-star ratings, the highest willingness to recommend rating, tied for the highest overall rating of 4.6/5, and the most verified reviews of any vendor in the report, based on 153 overall responses as of August 2026. Identity is the...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 15.09.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 738,751.30 21.706 ...
-
Jeff Black Joins Alliant Insurance Services’ Midwest Employee Benefits Team
IRVINE, Calif.--(BUSINESS WIRE)--Jeff Black has joined Alliant Insurance Services as Senior Vice President within its Employee Benefits Group. The Chicago-based consultant will advise a diverse portfolio of clients on human capital and benefits strategies designed to support growth, organizational transformation, and critical business initiatives. “Jeff brings an exceptional ability to connect human capital strategy with the broader priorities driving an organization,” said Kevin Overbey, Presi...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 15.09.2026 FBTU.LN IE00BL0L0H60 500,002.00 USD 16,105,777.15 32.211 ...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development
FARGO, N.D. & CORALVILLE, Iowa--(BUSINESS WIRE)--IDT and Aldevron launch research grade S.p. Cas9 mRNA in wild type and SpyFi™ formats, supporting CRISPR genome editing research to development....
-
ClearNote Health to Showcase Power of 5hmC Signatures for Treatment Monitoring at AACR Conference on Pancreatic Cancer
SAN DIEGO--(BUSINESS WIRE)--ClearNote Health will present new data for its Avantect® Pancreatic Cancer Test and its Virtuoso® platform at the AACR Conference on Pancreatic Cancer...
-
THE BALDWIN GROUP (BWIN): Kaskela Law Announces Probe into Adequacy of $32.50 Per Share Buyout Price – Fair or Inadequately Low for Baldwin’s Shareholders?
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating the sufficiency of The Baldwin Group, Inc. (NASDAQ: BWIN) (“Baldwin”) shareholder buyout proposal to determine whether Baldwin investors may be able to obtain a higher price for their shares. Sign up here to receive additional information: https://kaskelalaw.com/case/baldwin-group-buyout/ On September 14, 2026, Baldwin reported that it would be acquired by Sequence Holdings and DFO Management at a price of $32.50 per share in cash. Fol...